EVAXION BIOTECH A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About EVAXION BIOTECH A/S
EVAXION BIOTECH A/S (CVR number: 31762863) is a company from RUDERSDAL. The company recorded a gross profit of 0 kDKK in 2022. The operating profit was -180.5 mDKK, while net earnings were -164.3 mDKK. The profitability of the company measured by Return on Assets (ROA) was -76.9 %, which can be considered poor and Return on Equity (ROE) was -121.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 38.2 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. EVAXION BIOTECH A/S's liquidity measured by quick ratio was 4.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | |||||
EBIT | -72 649.00 | -92 847.00 | - 183 407.00 | - 180 483.00 | |
Net earnings | -74 842.00 | -97 918.00 | - 154 885.00 | - 164 292.00 | |
Shareholders equity total | 62 499.00 | 42 615.00 | 212 818.00 | 57 888.00 | |
Balance sheet total (assets) | 73 996.00 | 70 493.00 | 263 012.00 | 150 437.00 | |
Net debt | -63 814.00 | -34 758.00 | - 201 815.00 | -24 676.00 | |
Profitability | |||||
EBIT-% | |||||
ROA | -97.6 % | -141.2 % | -94.5 % | -76.9 % | |
ROE | -119.7 % | -186.3 % | -121.3 % | -121.4 % | |
ROI | -115.6 % | -194.1 % | -113.1 % | -86.1 % | |
Economic value added (EVA) | 1 266.23 | -67 675.64 | -78 968.88 | - 166 620.74 | - 149 076.70 |
Solvency | |||||
Equity ratio | 84.5 % | 60.5 % | 80.6 % | 38.2 % | |
Gearing | 3.7 % | 104.6 % | |||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 6.4 | 2.2 | 8.0 | 4.8 | |
Current ratio | 6.4 | 2.2 | 8.0 | 4.8 | |
Cash and cash equivalents | 63 814.00 | 34 758.00 | 209 641.00 | 85 237.00 | |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.